col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


63 Results       Page 1

 [1] 
Springer Science and Business Media LLC: Nature Microbiology
  original article Date Title Authors   All Authors
1 [GO] 2022―Sep―16 Publisher Correction: SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway Brian J. Willett, Joe Grove, Oscar A. MacLean, Craig Wilkie, Giuditta De Lorenzo, Wilhelm Furnon, et al. (+686)
2 [GO] 2022―Aug―18 Genomic epidemiology of the SARS-CoV-2 epidemic in Brazil Marta Giovanetti, Svetoslav Nanev Slavov, Vagner Fonseca, Eduan Wilkinson, Houriiyah Tegally, José Salvatore Leister Patané, et al. (+97)
3 [GO] 2022―Aug―02 COVID-19-associated fungal infections Martin Hoenigl, Danila Seidel, Rosanne Sprute, Cristina Cunha, Matteo Oliverio, Gustavo H. Goldman, et al. (+2)
4 [GO] 2022―Jul―25 Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys Craig Fenwick, Priscilla Turelli, Dongchun Ni, Laurent Perez, Kelvin Lau, Cécile Herate, et al. (+20)
5 [GO] 2022―Jul―18 Early detection and surveillance of SARS-CoV-2 genomic variants in wastewater using COJAC Katharina Jahn, David Dreifuss, Ivan Topolsky, Anina Kull, Pravin Ganesanandamoorthy, Xavier Fernandez-Cassi, et al. (+18)
6 [GO] 2022―Jul―14 Neutralizing antibody activity against 21 SARS-CoV-2 variants in older adults vaccinated with BNT162b2 Joseph Newman, Nazia Thakur, Thomas P. Peacock, Dagmara Bialy, Ahmed M. E. Elrefaey, Carlijn Bogaardt, et al. (+10)
7 [GO] 2022―Jul―12 Omicron: a shift in the biology of SARS-CoV-2
8 [GO] 2022―Jul―07 SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway Brian J. Willett, Joe Grove, Oscar A. MacLean, Craig Wilkie, Giuditta De Lorenzo, Wilhelm Furnon, et al. (+686)
9 [GO] 2022―Jun―30 Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2 Xiaoyu Sun, Chunyan Yi, Yuanfei Zhu, Longfei Ding, Shuai Xia, Xingchen Chen, et al. (+32)
10 [GO] 2022―Jun―15 Therapeutic efficacy of monoclonal antibodies and antivirals against SARS-CoV-2 Omicron BA.1 in Syrian hamsters Ryuta Uraki, Maki Kiso, Masaki Imai, Seiya Yamayoshi, Mutsumi Ito, Seiichiro Fujisaki, et al. (+9)
11 [GO] 2022―Jun―09 Inactivated whole-virion vaccine BBV152/Covaxin elicits robust cellular immune memory to SARS-CoV-2 and variants of concern Rajesh Vikkurthi, Asgar Ansari, Anupama R. Pai, Someshwar Nath Jha, Shilpa Sachan, Suvechchha Pandit, et al. (+21)
12 [GO] 2022―May―30 Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia Anupriya Aggarwal, Alberto Ospina Stella, Gregory Walker, Anouschka Akerman, Camille Esneau, Vanessa Milogiannakis, et al. (+36)
13 [GO] 2022―May―23 Author Correction: Differential neutralizing antibody responses elicited by CoronaVac and BNT162b2 against SARS-CoV-2 Lambda in Chile Mónica L. Acevedo, Aracelly Gaete-Argel, Luis Alonso-Palomares, Marco Montes de Oca, Andrés Bustamante, Aldo Gaggero, et al. (+10)
14 [GO] 2022―May―05 Postdoctoral life in a pandemic Ann C. Gregory
15 [GO] 2022―Apr―28 Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness Ruian Ke, Pamela P. Martinez, Rebecca L. Smith, Laura L. Gibson, Agha Mirza, Madison Conte, et al. (+33)
16 [GO] 2022―Apr―28 SARS-CoV-2-specific T-cell epitope repertoire in convalescent and mRNA-vaccinated individuals Julia Lang-Meli, Hendrik Luxenburger, Katharina Wild, Vivien Karl, Valerie Oberhardt, Elahe Salimi Alizei, et al. (+21)
17 [GO] 2022―Apr―27 An orally available Mpro inhibitor is effective against wild-type SARS-CoV-2 and variants including Omicron Bao-Xue Quan, Huiping Shuai, An-Jie Xia, Yuxin Hou, Rui Zeng, Xin-Lei Liu, et al. (+22)
18 [GO] 2022―Apr―01 Differential neutralizing antibody responses elicited by CoronaVac and BNT162b2 against SARS-CoV-2 Lambda in Chile Mónica L. Acevedo, Aracelly Gaete-Argel, Luis Alonso-Palomares, Marco Montes de Oca, Andrés Bustamante, Aldo Gaggero, et al. (+10)
19 [GO] 2022―Feb―07 Longitudinal analysis of antibody dynamics in COVID-19 convalescents reveals neutralizing responses up to 16 months after infection Yang Yang, Minghui Yang, Yun Peng, Yanhua Liang, Jinli Wei, Li Xing, et al. (+11)
20 [GO] 2022―Feb―07 Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario Sharifa Nasreen, Hannah Chung, Siyi He, Kevin A. Brown, Jonathan B. Gubbay, Sarah A. Buchan, et al. (+10)
21 [GO] 2022―Jan―11 Increased small particle aerosol transmission of B.1.1.7 compared with SARS-CoV-2 lineage A in vivo Julia R. Port, Claude Kwe Yinda, Victoria A. Avanzato, Jonathan E. Schulz, Myndi G. Holbrook, Neeltje van Doremalen, et al. (+3)
22 [GO] 2022―Jan―10 Induction of robust cellular and humoral immunity against SARS-CoV-2 after a third dose of BNT162b2 vaccine in previously unresponsive older adults Addi J. Romero-Olmedo, Axel Ronald Schulz, Svenja Hochstätter, Dennis Das Gupta, Iiris Virta, Heike Hirseland, et al. (+11)
23 [GO] 2022―Jan―10 Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California Venice Servellita, Mary Kate Morris, Alicia Sotomayor-Gonzalez, Amelia S. Gliwa, Erika Torres, Noah Brazer, et al. (+22)
24 [GO] 2021―Dec―31 Nowcasting the spread of SARS-CoV-2 Hagai Rossman, Eran Segal
25 [GO] 2021―Dec―31 Improving local prevalence estimates of SARS-CoV-2 infections using a causal debiasing framework George Nicholson, Brieuc Lehmann, Tullia Padellini, Koen B. Pouwels, Radka Jersakova, James Lomax, et al. (+6)
26 [GO] 2021―Dec―14 Synthetic DNA spike-ins (SDSIs) enable sample tracking and detection of inter-sample contamination in SARS-CoV-2 sequencing workflows Kim A. Lagerborg, Erica Normandin, Matthew R. Bauer, Gordon Adams, Katherine Figueroa, Christine Loreth, et al. (+18)
27 [GO] 2021―Oct―22 Children primed and ready for SARS-CoV-2 Emily Speranza
28 [GO] 2021―Oct―15 Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern Liane Dupont, Luke B. Snell, Carl Graham, Jeffrey Seow, Blair Merrick, Thomas Lechmere, et al. (+26)
29 [GO] 2021―Sep―27 Lung microbiota and COVID-19 severity Robert P. Dickson
30 [GO] 2021―Sep―21 Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail Jinhui Dong, Seth J. Zost, Allison J. Greaney, Tyler N. Starr, Adam S. Dingens, Elaine C. Chen, et al. (+26)
31 [GO] 2021―Sep―08 Genomics, social media and mobile phone data enable mapping of SARS-CoV-2 lineages to inform health policy in Bangladesh Lauren A. Cowley, Mokibul Hassan Afrad, Sadia Isfat Ara Rahman, Md Mahfuz Al Mamun, Taylor Chin, Ayesha Mahmud, et al. (+16)
32 [GO] 2021―Sep―01 Cellular host factors for SARS-CoV-2 infection Jim Baggen, Els Vanstreels, Sander Jansen, Dirk Daelemans
33 [GO] 2021―Aug―31 Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome Imran Sulaiman, Matthew Chung, Luis Angel, Jun-Chieh J. Tsay, Benjamin G. Wu, Stephen T. Yeung, et al. (+46)
34 [GO] 2021―Aug―16 SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution Jiří Zahradník, Shir Marciano, Maya Shemesh, Eyal Zoler, Daniel Harari, Jeanne Chiaravalli, et al. (+12)
35 [GO] 2021―Jul―21 Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom Jia Wei, Nicole Stoesser, Philippa C. Matthews, Daniel Ayoubkhani, Ruth Studley, Iain Bell, et al. (+64)
36 [GO] 2021―Jun―30 How SARS-CoV-2 makes the cut Markus Hoffmann, Stefan Pöhlmann
37 [GO] 2021―Jun―23 Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda Daniel Lule Bugembe, My V. T. Phan, Isaac Ssewanyana, Patrick Semanda, Hellen Nansumba, Beatrice Dhaala, et al. (+5)
38 [GO] 2021―Jun―09 SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse Frank Konings, Mark D. Perkins, Jens H. Kuhn, Mark J. Pallen, Erik J. Alm, Brett N. Archer, et al. (+41)
39 [GO] 2021―Apr―27 The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets Thomas P. Peacock, Daniel H. Goldhill, Jie Zhou, Laury Baillon, Rebecca Frise, Olivia C. Swann, et al. (+14)
40 [GO] 2021―Mar―16 ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity GuanQun Liu, Jung-Hyun Lee, Zachary M. Parker, Dhiraj Acharya, Jessica J. Chiang, Michiel van Gent, et al. (+5)
41 [GO] 2021―Jan―29 Addendum: A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology Andrew Rambaut, Edward C. Holmes, Áine O’Toole, Verity Hill, John T. McCrone, Christopher Ruis, et al. (+2)
42 [GO] 2021―Jan―27 Author Correction: Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland Ana da Silva Filipe, James G. Shepherd, Thomas Williams, Joseph Hughes, Elihu Aranday-Cortes, Patawee Asamaphan, et al. (+46)
43 [GO] 2021―Jan―18 Publisher Correction: Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland Ana da Silva Filipe, James G. Shepherd, Thomas Williams, Joseph Hughes, Elihu Aranday-Cortes, Patawee Asamaphan, et al. (+46)
44 [GO] 2021―Jan―18 Author Correction: Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets Dhiraj Kumar Singh, Bindu Singh, Shashank R. Ganatra, Michal Gazi, Journey Cole, Rajesh Thippeshappa, et al. (+56)
45 [GO] 2020―Dec―21 Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland Ana da Silva Filipe, James G. Shepherd, Thomas Williams, Joseph Hughes, Elihu Aranday-Cortes, Patawee Asamaphan, et al. (+46)
46 [GO] 2020―Dec―21 The SARS-CoV-2 RNA-protein interactome in infected human cells Nora Schmidt, Caleb A. Lareau, Hasmik Keshishian, Sabina Ganskih, Cornelius Schneider, Thomas Hennig, et al. (+15)
47 [GO] 2020―Dec―18 Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets Dhiraj Kumar Singh, Bindu Singh, Shashank R. Ganatra, Michal Gazi, Journey Cole, Rajesh Thippeshappa, et al. (+56)
48 [GO] 2020―Dec―03 Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets Robert M. Cox, Josef D. Wolf, Richard K. Plemper
49 [GO] 2020―Nov―16 Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals Jian Zhang, Qian Wu, Ziyan Liu, Qijie Wang, Jiajing Wu, Yabin Hu, et al. (+28)
50 [GO] 2020―Nov―02 How to establish an academic SARS-CoV-2 testing laboratory Alex Richter, Tim Plant, Michael Kidd, Andrew Bosworth, Megan Mayhew, Oliver Megram, et al. (+7)
51 [GO] 2020―Oct―26 Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans Jeffrey Seow, Carl Graham, Blair Merrick, Sam Acors, Suzanne Pickering, Kathryn J. A. Steel, et al. (+36)
52 [GO] 2020―Oct―21 Language matters in a pandemic
53 [GO] 2020―Oct―07 Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters Shuofeng Yuan, Runming Wang, Jasper Fuk-Woo Chan, Anna Jinxia Zhang, Tianfan Cheng, Kenn Ka-Heng Chik, et al. (+8)
54 [GO] 2020―Sep―10 Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies Wen Shi Lee, Adam K. Wheatley, Stephen J. Kent, Brandon J. DeKosky
55 [GO] 2020―Jul―28 Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic Maciej F. Boni, Philippe Lemey, Xiaowei Jiang, Tommy Tsan-Yuk Lam, Blair W. Perry, Todd A. Castoe, et al. (+2)
56 [GO] 2020―Jul―24 Research funding after COVID-19 Miguel Prudêncio, Joana C. Costa
57 [GO] 2020―Jul―23 LY6E impairs coronavirus fusion and confers immune control of viral disease Stephanie Pfaender, Katrina B. Mar, Eleftherios Michailidis, Annika Kratzel, Ian N. Boys, Philip V’kovski, et al. (+21)
58 [GO] 2020―Jul―15 A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology Andrew Rambaut, Edward C. Holmes, Áine O’Toole, Verity Hill, John T. McCrone, Christopher Ruis, et al. (+2)
59 [GO] 2020―Jul―10 Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR primer-probe sets Chantal B. F. Vogels, Anderson F. Brito, Anne L. Wyllie, Joseph R. Fauver, Isabel M. Ott, Chaney C. Kalinich, et al. (+39)
60 [GO] 2020―May―20 Antimicrobial resistance in the age of COVID-19
61 [GO] 2020―Apr―07 SARS-CoV-2 detection in patients with influenza-like illness Wen-Hua Kong, Yao Li, Ming-Wei Peng, De-Guang Kong, Xiao-Bing Yang, Leyi Wang, Man-Qing Liu
62 [GO] 2020―Mar―02 The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
63 [GO] 2020―Feb―24 Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses Michael Letko, Andrea Marzi, Vincent Munster
 [1] 

63 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.012 sec